ELVN
Enliven Therapeutics, Inc. - Common Stock (ELVN)
$87
About Enliven Therapeutics, Inc. - Common Stock (ELVN)
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.
Details
Daily high
$49.52
Daily low
$47.98
Price at open
$49.45
52 Week High
$62.32
52 Week Low
$14.78
Market cap
3.6B
Dividend yield
-
Volume
2.3M
Avg. volume
1.4M
P/E ratio
-29.64
Enliven Therapeutics, Inc. - Common Stock News
Details
Daily high
$49.52
Daily low
$47.98
Price at open
$49.45
52 Week High
$62.32
52 Week Low
$14.78
Market cap
3.6B
Dividend yield
-
Volume
2.3M
Avg. volume
1.4M
P/E ratio
-29.64